Prostate
Cancer: ruling out false alarms
April
4, 2000
SAN
FRANCISCO, APR 3 (UNB/AP) - Fine-tuning the standard screening test for
prostate cancer can help doctors reduce false
alarms by up to 40 percent and perhaps
find early-stage tumors that might otherwise be missed,
researchers say.
About
three-quarters of men with prostate cancer have elevated levels
of a protein called prostate-specific antigen - PSA. Testing blood
for PSA has been a standard screening method for older men since
about 1990.
|